Center-Authored Papers

Filters: Author is Cowan, Frances  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
J
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD et al..  2011.  A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.. AIDS and behavior. 15(5):897-904. Abstract
K
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
L
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L et al..  2012.  Acyclovir achieves lower concentration in African HIV-seronegative, HSV-2 seropositive women compared to non-African populations.. Antimicrobial agents and chemotherapy. 56(5):2777-9. Abstract